How ongoing sterility issues set off a massive eye drop recall

A California-based company has issued a recall for over 3.1 million bottles of lubricating eye drops due to concerns about sterility. The recall affects products purchased since April 2025, as the company failed to conduct proper testing to confirm the sterility of the eye drops. This oversight raises potential health risks for consumers who rely on these products for eye lubrication. Ensuring the sterility of eye drops is crucial to prevent infections and other complications that could arise from using contaminated products. The recall highlights the importance of rigorous testing and quality control in the manufacturing of healthcare products to ensure consumer safety. QUESTION: How might this recall influence the way companies approach product testing and quality assurance in the future?